Rhenium-186
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Rhenium-186, covering 2025-07-11 to 2025-07-11. Get the full timeline:
Most recent: Clinical Trial Update: Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma [Phase 1]